12: Frost gets iced
Armchair Healthcare
English - September 17, 2018 06:00 - 42 minutes - 46.6 MB - ★★★★★ - 11 ratingsInvesting Business Science healthcare pharmaceuticals biotech biotechnology stock market drugs placebo science shorting stocks finance Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: 11: Sangamania
Next Episode: 13: Disclosures and Lies
Gilead and Amgen had great data, Vital, not so much and we also talk about Phil Frost finally getting charged by the SEC. Here's an index:
00:47 - AMG-420 data from Amgen in multiple myeloma
04:29 - Gilead/Galapagos RA data for filgotinib
10:30 - Phil Frost gets charged by the SEC for stock pump and dumps
16:28 - Vital Therapies fails again
22:57 - The Immortal Life of Henrietta Lacks
26:00 - The California Institute for Regenerative Medicine boondoggle
31:36 - Moderna's $10 billion IPO
33:10 - Foamix's data in Acne
38:48 - The study that said low carb is bad for you was REALLY poorly designed